Sarepta has refused to suspend all dosing of its gene therapy for Duchenne muscular dystrophy, Elevidys, defying a clinical ...

The U.S. Food and Drug Administration ( FDA) has placed an immediate clinical hold on Sarepta Therapeutics' investigational ...

Sarepta Therapeutics lays off 493 workers amid FDA probe, stock drop, and concerns over its gene therapy treatment, Elevidys.

Retail chatter spiked last week as investors piled into three healthcare stocks: GlucoTrack, Sarepta Therapeutics, and TNF ...

The company issued a statement late Friday after stock markets closed that said it would “continue to ship Elevidys to the ambulant population,” following a request from the Food and Drug ...

Resorts in Spain and Portugal are the most popular destinations for UK holidaymakers this summer, according to a new report.